- Home
- DVAX vs WGO Comparison
DVAX vs WGO Comparison
Compare DVAX & WGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVAX
- WGO
- Stock Information
- Founded
- DVAX 1996
- WGO 1958
- Country
- DVAX United States
- WGO United States
- Employees
- DVAX N/A
- WGO N/A
- Industry
- DVAX Biotechnology: Pharmaceutical Preparations
- WGO Homebuilding
- Sector
- DVAX Health Care
- WGO Industrials
- Exchange
- DVAX Nasdaq
- WGO Nasdaq
- Market Cap
- DVAX 1.2B
- WGO 1.1B
- IPO Year
- DVAX 2004
- WGO N/A
- Fundamental
- Price
- DVAX $10.44
- WGO $41.02
- Analyst Decision
- DVAX Buy
- WGO Buy
- Analyst Count
- DVAX 4
- WGO 12
- Target Price
- DVAX $26.50
- WGO $40.80
- AVG Volume (30 Days)
- DVAX 1.3M
- WGO 735.7K
- Earning Date
- DVAX 11-05-2025
- WGO 10-22-2025
- Dividend Yield
- DVAX N/A
- WGO 3.49%
- EPS Growth
- DVAX N/A
- WGO 106.82
- EPS
- DVAX N/A
- WGO 0.91
- Revenue
- DVAX $316,268,000.00
- WGO $2,798,200,000.00
- Revenue This Year
- DVAX $23.23
- WGO $3.71
- Revenue Next Year
- DVAX $16.57
- WGO $6.31
- P/E Ratio
- DVAX N/A
- WGO $45.27
- Revenue Growth
- DVAX 26.66
- WGO N/A
- 52 Week Low
- DVAX $9.20
- WGO $28.00
- 52 Week High
- DVAX $14.63
- WGO $65.65
- Technical
- Relative Strength Index (RSI)
- DVAX 58.99
- WGO 71.48
- Support Level
- DVAX $10.03
- WGO $29.55
- Resistance Level
- DVAX $10.59
- WGO $41.87
- Average True Range (ATR)
- DVAX 0.22
- WGO 1.43
- MACD
- DVAX 0.06
- WGO 1.27
- Stochastic Oscillator
- DVAX 81.25
- WGO 93.24
About DVAX Dynavax Technologies Corporation
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
About WGO Winnebago Industries Inc.
Winnebago Industries manufactures Class A, B, and C motor homes along with towables, customized specialty vehicles, boats, and parts. Headquartered in Eden Prairie, Minnesota, Winnebago has been producing recreational vehicles since 1958. Revenue was nearly $3 billion in fiscal 2024. Winnebago expanded into towables in 2011 with the acquisition of SunnyBrook and acquired Grand Design in November 2016. Towables made up 83% of the firm's RV unit volume, up from 31% in fiscal 2016. The company's total RV unit volume was 38,796 in fiscal 2024. Winnebago expanded into boating in 2018 with the purchase of Chris-Craft, bought premium motor home maker Newmar in November 2019, and bought Barletta pontoon boats in August 2021. It also is developing electric and autonomous technology.